Cel-Sci
CVM
#10585
Rank
A$39.72 M
Marketcap
A$2.26
Share price
3.85%
Change (1 day)
-87.82%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2026 (TTM): -A$33.15 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$32.41 Million, an increase over its 2024 earnings that were of -A$37.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$33.15 Million2.31%
2025 -A$32.41 Million-12.52%
2024 -A$37.04 Million-12.41%
2023 -A$42.29 Million-12.87%
2022 -A$48.53 Million-3.42%
2021 -A$50.26 Million13.44%
2020 -A$44.3 Million11.28%
2019 -A$39.81 Million179.81%
2018 -A$14.23 Million-48.72%
2017 -A$27.75 Million-16.23%
2016 -A$33.12 Million-23.63%
2015 -A$43.37 Million-5.47%
2014 -A$45.88 Million198.49%
2013 -A$15.37 Million
2010 -A$17.94 Million
2004 -A$6.07 Million12.38%
2003 -A$5.4 Million-16.59%
2002 -A$6.47 Million-59.28%
2001 -A$15.89 Million23.17%
2000 -A$12.9 Million20.12%
1999 -A$10.74 Million13.24%
1998 -A$9.48 Million-20%
1997 -A$11.85 Million46.55%
1996 -A$8.09 Million34.88%
1995 -A$6 Million2.38%
1994 -A$5.86 Million68%
1993 -A$3.49 Million78.57%
1992 -A$1.96 Million180%
1991 -A$0.7 Million25%
1990 -A$0.56 Million-0%
1989 -A$0.56 Million-71.43%
1988 -A$1.96 Million-0%
1987 -A$1.96 Million-46.15%
1986 -A$3.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.21 B-117,148.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.66 B-41,041.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-A$0.24 Billion 665.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-A$9.43 Million-69.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.16 B-10,332.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-A$0.64 Billion 1,946.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.39 M-366.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$20.8 Million-32.79%๐Ÿ‡บ๐Ÿ‡ธ USA